Jump to section
Related Articles
Cited By...
- Phase 1 Evaluation of 11C-CS1P1 to Assess Safety and Dosimetry in Human Participants
- Repurposing bromocriptine for A{beta} metabolism in Alzheimers disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimers disease with presenilin 1 (PSEN1) mutations
- The Synthesis and Structural Requirements for Measuring Glucocorticoid Receptor Expression In Vivo with ({+/-})-11C-YJH08 PET
- Biodistribution and Radiation Dosimetry of 11C-Nicotine from Whole-Body PET Imaging in Humans
- Human Radiation Dosimetry for the N-Methyl-D-Aspartate Receptor Radioligand 11C-CNS5161
- Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology
- Dual-Biomarker Imaging of Regional Cerebral Amyloid Load and Neuronal Activity in Dementia with PET and 11C-Labeled Pittsburgh Compound B
- Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging
- Consideration of Optimal Time Window for Pittsburgh Compound B PET Summed Uptake Measurements
- Radiation Dosimetry of {beta}-Amyloid Tracers 11C-PiB and 18F-BAY94-9172
- 1-11C-Methyl-4-Piperidinyl-N-Butyrate Radiation Dosimetry in Humans by Dynamic Organ-Specific Evaluation